SINGAPORE - Media OutReach Newswire - 22 December 2025 - Pyxis, a leading Singapore-based maritime electrification startup, has secured S$13 million in the first close of its S$18 million growth ...

Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...

LONDON, Nov. 18, 2025 /PRNewswire/ -- Compass Box Scotch Whiskymakers announce the launch of Pyxis, a first-of-its-kind AI-powered whisky guide designed to make exploration more personal, effortless, ...

Pyxis Oncology , Inc. (NASDAQ:PYXS) reported the retirement of Pamela Connealy from her roles as Chief Financial Officer and Chief Operating Officer, effective Tuesday. According to a statement based ...

Advanced digital film camera in a versatile design with revolutionary full frame 12K RGBW sensor in EF, PL or L-Mount, Blackmagic RAW and global media sync with Blackmagic Cloud! Blackmagic PYXIS 12K ...

Advanced digital film camera in a versatile design with revolutionary full frame 12K RGBW sensor in EF, PL or L-Mount, Blackmagic RAW and global media sync with Blackmagic Cloud! NAB 2025 -Blackmagic ...

With huge banners announcing it already plastered all over the LVCC, the PYXIS 12K is not exactly one of NAB 2025's surprises, but the official unveil is all about a rather interesting new camera at a ...

Having recently trimmed back its pipeline to a sole cancer candidate, Pyxis Oncology has now reduced its head count to match. The Boston biotech is shrinking its workforce by "approximately" 20%, it ...

The completion of the $3.0 million common share repurchase program demonstrates Pyxis Tankers' commitment to returning value to shareholders and potentially enhancing share price. Redemption of all ...

The first reviews of the Blackmagic PYXIS 6K are starting to circulate, with Sean Viljoen’s video of filming with it at the Imire Game Reserve in Zimbabwe showcasing some impressive capabilities. Sean ...

On Wednesday, Pyxis Oncology, Inc. (NASDAQ:PYXS) released preliminary data from the ongoing Phase 1 clinical dose escalation study evaluating PYX-201 in multiple solid tumors. Among evaluable Head and ...

Stephens has initiated coverage on Pyxis Oncology Inc (NASDAQ:PYXS), highlighting the company’s technology platform aimed at developing next-gen antibody-drug conjugates (ADCs) with enhanced potency, ...